With vaccine hesitancy on the rise, Covid vaccine makers are pushing forward with clinical trials on adults.
The most recent studies to begin are trials of the vaccinated receiving a different vaccine booster shot around 3-4 months later.
Fauci initially said those taking the vaccine would need a booster shot at some point, so it should come as no surprise more Covid vaccine studies are underway.
The National Institutes of Health (NIH) made this announcement on June 1st.
News: NIH clinical trial evaluating mixed COVID-19 vaccine schedules begins https://t.co/5eJRfFQnVK
— NIH (@NIH) June 1, 2021
Right now, three Covid vaccines are authorized in America: Johnson & Johnson, Pfizer-BioNTech, and Moderna.
Apparently, the study will determine the safety and immunogenicity of mixed boosted regimens against Covid.
Here is more about the new clinical trials from the NIH website:
The National Institutes of Health has started a Phase 1/2 clinical trial in which adult volunteers who have been fully vaccinated against COVID-19 will receive booster doses of different COVID-19 vaccines to determine the safety and immunogenicity of mixed boosted regimens. The National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, is leading and funding the study through the Infectious Diseases Clinical Research Consortium, a clinical trials network that encompasses the Institute’s long-standing Vaccine and Treatment Evaluation Units (VTEUs).
“Although the vaccines currently authorized by the U.S. Food and Drug Administration offer strong protection against COVID-19, we need to prepare for the possibility of needing booster shots to counter waning immunity and to keep pace with an evolving virus,” said NIAID Director Anthony S. Fauci, M.D. “The results of this trial are intended to inform public health policy decisions on the potential use of mixed vaccine schedules should booster doses be indicated.”
The trial is led by principal investigators Robert L. Atmar, M.D., at Baylor College of Medicine, Houston, and Kirsten E. Lyke, M.D., at the University of Maryland, College Park. It will include approximately 150 individuals who already have received one of the three COVID-19 vaccine regimens currently available under FDA Emergency Use Authorization in the United States: the Janssen COVID-19 vaccine (also referred to as the Johnson & Johnson vaccine, or Ad26.COV2-S), the Moderna COVID-19 vaccine (also known as mRNA-1273), and the Pfizer-BioNTech COVID-19 vaccine (also known as (BNT162b2). Each vaccine group will enroll about 25 people ages 18 through 55 years and approximately 25 people age 56 years and older. Twelve to 20 weeks following their initial vaccination regimen, participants will receive a single booster dose of the Moderna COVID-19 vaccine as part of the trial.
People who have not yet received an FDA authorized COVID-19 vaccine are also eligible to enroll in the trial in a separate cohort. Initially, these volunteers will receive the two-dose Moderna COVID-19 vaccine regimen and will be assigned to receive a booster dose of a vaccine about 12 to 20 weeks later.
The trial has an adaptive design and may add arms as vaccines are awarded EUA and/or variant lineage vaccines become available for evaluation.
All trial participants will be followed for one year after receiving their last vaccination as part of the study. They will be asked to complete telephone check-ins and various in-person follow up visits. Trial investigators will evaluate participants for safety and any side effects post-vaccination. Participants also will be asked to provide blood samples periodically so that trial investigators can evaluate immune responses against current circulating strains of SARS-CoV-2, as well as emerging variants. If trial participants develop laboratory-confirmed symptomatic COVID-19, investigators will perform genetic sequence analyses on the participant samples to see if a variant strain of SARS-CoV-2 caused the infection.
Initial trial results are expected in late summer 2021. For more information about the trial, including a list of enrollment locations, please visit clinicaltrials.gov and search identifier NCT04889209.
Should we really be undertaking more Covid vaccine studies based on fraudster Fauci’s suggestions?
Even President Trump came out on Thursday to speak about Flip-Flop Fauci and how we all are fortunate He didn’t listen to Fauci.
Below is what President Trump said via Telegram:
After seeing the emails, our Country is fortunate I didn’t do what Dr. Fauci wanted me to do. For instance, I closed our Borders to China very early despite his not wanting them closed. The Democrats and the Fake News Media even called me a “xenophobe.” In the end, we saw this was a life-saving decision, and likewise with closing our borders to Europe, specifically to certain heavily infected countries. I was later given credit, even by “Tony,” for saving hundreds of thousands of lives. Dr. Fauci also didn’t put an emphasis on speed of vaccine production because he thought it would take 3, 4, or maybe even 5 years to create. I got it done in less than 9 months with Operation Warp Speed. In retrospect, the vaccine is saving the world. Then, I placed the greatest bet in history. We ordered billions of dollars’ worth of vaccines before we knew it even worked. Had that not been done, our wonderful vaccines would not have been administered until October of this year. No one would’ve had the shot that has now saved the world and millions of lives!
Also, Dr. Fauci was totally against masks when even I thought they would at least be helpful. He then changed his mind completely and became a radical masker!
There are a lot of questions that must be answered by Dr. Fauci. The funding of Wuhan by the U.S. was foolishly started by the Obama Administration in 2014 but ended under the Trump Administration. When I heard about it, I said “no way.” What did Dr. Fauci know about “gain of function” research, and when did he know it?
Sadly, all disastrous side effects could have been avoided if we never listened to Fauci and the CDC in the first place.
These studies needlessly put the participants at risk.
Especially for such a non-deadly virus, why risk causing more harm than good?
By moving forward with unnecessary studies, the NIH is neglecting to pay attention to the life-threatening side-effects experienced by the vaccinated.
Stories are shared every day of someone surviving a “rare” side effect of this experimental drug.
Here is a video from a woman who had a blood clot in her brain after the experimental Johnson & Johnson vaccine was administered.
She recorded her story on Rumble to share, and we pray for her swift recovery:
Should we really move forward with more Covid vaccine clinical trials based on Fauci’s direction?
I pray the rest of America wakes up to the answer.